Overview
Beijing Yuansheng Kangtai Gene Technology is described as China’s first national high-tech enterprise using nanopore sequencing for real-time, precise, dual-dimensional rapid pathogen testing. Independently developed the Yuanhe integrated intelligent testing device, a pathogen knowledge base and a big-data cloud platform.
Funding
Amounts as reported; USD estimates shown only when they matchNo funding records are listed yet.
No funding rows to list.
Valuation
Amounts as reported; USD estimates shown only when they matchNo valuation records are listed yet.
No valuation rows to list.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
人工智能驱动的双维度感染患者病原体快速检测-点燃精准检测的未来 北京源生康泰基因科技有限公司是国内首家基于纳米孔测序技术实现双维度感染病原实时精准快检的国家高新技术企业。公司自主研发“源盒”智能检测一体机、病原体知识库及大数据云平台